AlzeCure Pharma Valuation
| ALZCUR Stock | SEK 1.19 0.16 15.53% |
Today, the firm appears to be overvalued. AlzeCure Pharma shows a prevailing Real Value of kr1.1 per share. The current price of the firm is kr1.19. Our model approximates the value of AlzeCure Pharma from analyzing the firm fundamentals such as Return On Equity of -1.55, current valuation of 173.51 M, and Shares Owned By Insiders of 41.31 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AlzeCure Pharma's price fluctuation is dangerous at this time. Calculation of the real value of AlzeCure Pharma is based on 3 months time horizon. Increasing AlzeCure Pharma's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AlzeCure Pharma is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AlzeCure Stock. However, AlzeCure Pharma's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.19 | Real 1.1 | Hype 1.19 | Naive 1.25 |
The real value of AlzeCure Stock, also known as its intrinsic value, is the underlying worth of AlzeCure Pharma Company, which is reflected in its stock price. It is based on AlzeCure Pharma's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AlzeCure Pharma's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AlzeCure Pharma helps investors to forecast how AlzeCure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AlzeCure Pharma more accurately as focusing exclusively on AlzeCure Pharma's fundamentals will not take into account other important factors: AlzeCure Pharma Total Value Analysis
AlzeCure Pharma is presently forecasted to have takeover price of 173.51 M with market capitalization of 254.44 M, debt of 0, and cash on hands of 222.05 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the AlzeCure Pharma fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
173.51 M | 254.44 M | 0 | 222.05 M |
AlzeCure Pharma Asset Utilization
One of the ways to look at asset utilization of AlzeCure is to check how much profit was generated for every dollar of assets it reports. AlzeCure Pharma shows a negative utilization of assets of -0.78 percent, losing kr0.007846 for each kronor of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each kronor of assets it shows. Put another way, asset utilization of AlzeCure Pharma shows how discouraging it operates for each kronor spent on its assets.AlzeCure Pharma Ownership Allocation
AlzeCure Pharma holds a total of 59.19 Million outstanding shares. AlzeCure Pharma retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.AlzeCure Pharma Profitability Analysis
Net Loss for the year was (77.78 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AlzeCure Pharma's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AlzeCure Pharma and how it compares across the competition.
About AlzeCure Pharma Valuation
The stock valuation mechanism determines AlzeCure Pharma's current worth on a weekly basis. Our valuation model uses a comparative analysis of AlzeCure Pharma. We calculate exposure to AlzeCure Pharma's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AlzeCure Pharma's related companies.AlzeCure Pharma AB develops therapies for the treatment of Alzheimer s disease and related neurodegenerative disorders. The company was founded in 2012 and is based in Huddinge, Sweden. AlzeCure Pharma is traded on Stockholm Stock Exchange in Sweden.
8 Steps to conduct AlzeCure Pharma's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates AlzeCure Pharma's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct AlzeCure Pharma's valuation analysis, follow these 8 steps:- Gather financial information: Obtain AlzeCure Pharma's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine AlzeCure Pharma's revenue streams: Identify AlzeCure Pharma's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research AlzeCure Pharma's industry and market trends, including the size of the market, growth rate, and competition.
- Establish AlzeCure Pharma's growth potential: Evaluate AlzeCure Pharma's management, business model, and growth potential.
- Determine AlzeCure Pharma's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate AlzeCure Pharma's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |